Elevated stress-hemoconcentration in major depression is normalized by antidepressant treatment: secondary analysis

Ma-Li Wong1, Chuanhui Dong, Karin Esposito

  • 1Department of Psychiatry and Behavioral Sciences, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, USA. mali@miami.edu

Plos One
|November 6, 2008
PubMed

Insights

Major depressive disorder (MDD) is linked to increased stress-hemoconcentration and blood viscosity. Antidepressant treatment improved these measures, suggesting a potential benefit for cardiovascular health in patients with depression.

Area of Science:

  • Cardiology
  • Psychiatry
  • Hematology

Background:

  • Major depressive disorder (MDD) is an independent risk factor for cardiovascular disease (CVD).
  • MDD presence in CVD patients correlates with worse cardiac outcomes after myocardial infarction (MI).
  • Stress-hemoconcentration, a potential CVD risk factor from psychological stress, is not well-studied in MDD.

Purpose of the Study:

  • To investigate stress-hemoconcentration in individuals with mild to moderate MDD.
  • To assess the impact of antidepressant treatment on stress-hemoconcentration and blood viscosity in MDD patients.

Main Methods:

  • Secondary analysis of data from a pharmacogenetic study.
  • Inclusion of controls and subjects with mild to moderate MDD.
  • Measurement of hematologic and hemorheologic markers, including blood cell counts, hematocrit, hemoglobin, total serum protein, albumin, and whole blood viscosity.

Main Results:

  • Individuals with MDD exhibited significantly higher hemorheologic measures and blood viscosity compared to controls.
  • These measures correlated with depression severity.
  • Antidepressant treatment for 8 weeks led to significant improvements in stress-hemoconcentration measures, including white blood cell count, red blood cell measures, and plasma volume, which correlated with reduced depression severity.

Conclusions:

  • Stress-hemoconcentration is present in mild to moderate MDD patients at baseline.
  • Antidepressant treatment improves hemorheologic measures and correlates with depression symptom improvement.
  • These findings suggest antidepressants may reduce cardiovascular risk by improving blood viscosity in depressed patients.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Introduction to Stress and Lifestyle01:27

Introduction to Stress and Lifestyle

Stress is a multifaceted response to events perceived as challenging or threatening, highlighting physical, emotional, cognitive, and behavioral reactions. Physically, stress can lead to fatigue, sleep disruptions, and various health issues such as frequent colds, chest pains, and nausea. Emotionally, it can manifest as anxiety, depression, irritability, and anger triggered by both minor and major life events. Cognitively, it may result in difficulty in concentration, memory, and...